$13.21
-0.32-2.37%
Last update: Oct 16, 4:00 PM
$13.21
-0.32-2.37%
Integra Lifesciences Holdings Corp
IARTNASDAQ
Integra Lifesciences (IART) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Integra Lifesciences (IART) last issued guidance on October 2, 2026 for fiscal year 2026. The company guided earnings per share in the range of $2.3 - $2.4, compared to a consensus EPS estimate of $2.46. Integra Lifesciences also guided revenue in the range of $1.63B - $1.65B for the period.
Compared to prior guidance, Integra Lifesciences lowered its EPS outlook from a previous range of $2.4 - $2.5. On the revenue side, the company lowered its revenue forecast from a prior range of $1.65B - $1.7B.
Integra Lifesciences has issued 39 guidance updates between October 26, 2022 and October 2, 2026. During this period, the company raised its outlook 10 times and lowered it 20 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.48 | $0.41 | $0.80 | $0.43 |
| Actual | $0.56 | $0.54 | $0.83 | $0.54 |
| Surprise | +16.7% | +31.7% | +3.75% | +25.6% |
| Revenue | ||||
| Estimate | $418.0M | $381.7M | $431.5M | $414.5M |
| Actual | $418.8M | $391.9M | $434.9M | $402.1M |
| Surprise | +0.18% | +2.67% | +0.79% | -3.00% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.56 | $0.75 | $0.51 | $0.59 |
| Revenue | ||||
| Consensus | $413.2M | $435.8M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $0.56 | $0.48 | 16.7 % |
| Q1 | May 5, 2026 | $0.54 | $0.41 | 31.7 % |
| Q4 | Feb 26, 2026 | $0.83 | $0.80 | 3.75 % |
| Q3 | Oct 30, 2025 | $0.54 | $0.43 | 25.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $418.76M | $418.01M | 0.18 % |
| Q1 | May 5, 2026 | $391.92M | $381.71M | 2.67 % |
| Q4 | Feb 26, 2026 | $434.93M | $431.51M | 0.79 % |
| Q3 | Oct 30, 2025 | $402.06M | $414.50M | -3.00 % |
